Issue Information.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.82
- Publication type:
- Article
Works matching IS 2769643X AND DT 2025 AND VI 4 AND IP 1
Results: 10
1
2
Cardiac Tissue Engineering Using Stimuli‐Responsive Biomaterials for the Targeted Therapy of Myocardial Infarction.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70009
- By:
- Publication type:
- Article
3
Photodynamic and Photothermal Effects of MXene Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> Under 460/808 nm Light Against Methicillin‐Resistant Staphylococcus aureus.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70007
- By:
- Publication type:
- Article
4
Restraining small extracellular vesicles: Dawn of a new era in nanomedicine.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70006
- By:
- Publication type:
- Article
5
Design of strong and tough biofibers and their biomedical applications.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70005
- By:
- Publication type:
- Article
6
One‐pot synthesis of tunable fluorescent polyethylene glycol (PEG) polymer for antimicrobial and anticancer theranostics.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70004
- By:
- Publication type:
- Article
7
Biofilm formation in cardiovascular infection and bioengineering approaches for treatment and prevention.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70003
- By:
- Publication type:
- Article
8
Simultaneous detection of dual targets Escherichia coli and Salmonella enteritidis using enzyme‐free strand displacement reaction.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70002
- By:
- Publication type:
- Article
9
The potency of aloe emodin‐loaded nanoparticles in conjunction with IFN‐γ for the pretreatment of mesenchymal stem cells with class II transactivator silence to alleviate severe acute pancreatitis.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70001
- By:
- Publication type:
- Article
10
A hydrogel miscible azelaic acid‐ionic liquids for the treatment of acne vulgaris: Enhanced solubility and skin retention.
- Published in:
- Medcomm: Biomaterials & Applications, 2025, v. 4, n. 1, p. 1, doi. 10.1002/mba2.70000
- By:
- Publication type:
- Article